MÖlnlycke® health care announces us $15m investment in next-generation enzymatic therapeutics company mediwound ltd

Gothenburg, sweden , july 15, 2024 /prnewswire/ -- mÖlnlycke health care, a world-leading medtech company specialising in solutions for wound care and surgical procedures, announced today an investment of us $15m in mediwound ltd. (nasdaq: mdwd) (mediwound) through a definitive share purchase agreement in a private investment in public equity (pipe).
MDWD Ratings Summary
MDWD Quant Ranking